Pomerantz LLP is investigating claims on behalf of investors of International Business Machines Corporation concerning potential securities fraud or unlawful business practices. The investigation follows IBM's July 14, 2026 release of second-quarter financial results, which the company described as disappointing due to a shortfall in its Z performance and associated software stack, primarily in Transaction Processing. IBM also disclosed that it had faltered and did not adapt quickly enough, causing numerous large deals to fail to close on expected timelines. On this news, IBM's stock price fell $73.16 per share, or 25.21%, to close at $217.07 per share on July 14, 2026. Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, extension 7980.
International Business MachinesIBM reported disappointing Q2 results with a shortfall in Z performance and large deals failing to close, causing a 25% stock drop.